Premier Biotech Acquires Desert Tox

Premier Biotech (ACP) Acquires OraSure Toxicology Line and Green Earth Biomedical's Mexican Subsidiary (GEM)

April 10, 2025

Medical Devices

Premier Biotech, a portfolio company of Align Capital Partners, acquired certain assets comprising OraSure Technologies' substance abuse testing business line and the Mexican subsidiary of Green Earth Biomedical LLC (GEM). The transactions expand Premier's oral-fluid toxicology product portfolio and accelerate its international distribution footprint in Mexico and Latin America.

Premier Biotech Acquires National Test Systems

November 5, 2025

Medical Devices

Premier Biotech, a portfolio company of Align Capital Partners, has acquired National Test Systems (NTS), a provider of rapid point-of-care drug screening supplies and services that serves more than 1,500 facilities across the United States. The acquisition expands Premier's point-of-care testing capabilities (including oral fluid testing) and deepens its presence in government and behavioral health end markets; NTS CEO Andrew Panico will remain involved to support the transition.

Enhesa Acquires ToxPlanet

July 5, 2022

Data & Analytics

Enhesa has acquired ToxPlanet, adding the world's largest chemical hazard and toxicology literature database to its regulatory and sustainability intelligence offerings. The deal expands Enhesa's sustainable chemistry and product compliance capabilities, integrating ToxPlanet's content-as-a-service database into Enhesa's global compliance platform.

Align Capital Partners Recapitalizes Premier Biotech

December 7, 2022

Medical Devices

Align Capital Partners has completed a recapitalization of Premier Biotech, a Minneapolis-based provider of point-of-care drugs of abuse testing devices and accredited laboratory services. Cascadia Capital served as exclusive financial advisor; Align will partner with management to scale the business, accelerate product development and expand the company's reach across workplace, government and clinical end markets.

Northlane Capital Partners Invests in United States Drug Testing Laboratories

January 13, 2025

Healthcare Services

Northlane Capital Partners has acquired United States Drug Testing Laboratories (USDTL), a Des Plaines, Illinois-based forensic toxicology laboratory, in a transaction in which NCP invested alongside USDTL's management and founders Veronica and Doug Lewis. NCP will partner with management to expand USDTL's niche forensic testing capabilities and has appointed Albert Berger as CEO to lead the company's next phase of growth.

National Dentex Labs Acquires Biotech Dental Prosthetics

January 10, 2022

Dental

National Dentex Labs (NDX) has acquired Biotech Dental Prosthetics of Palm Beach Gardens, Florida; terms were not disclosed. The Biotech lab will relocate into NDX’s Jupiter, Florida headquarters, with Biotech president Frank Lavonia III becoming general manager of NDX’s new lab; the acquisition expands NDX’s Florida footprint as its fifth full-service lab in the state.